EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 27-Apr-2025 00:08 ET (27-Apr-2025 04:08 GMT/UTC)

Immunotherapy success in KRAS G12C adenosquamous pancreatic cancer

Impact Journals LLC
Peer-Reviewed Publication

BUFFALO, NY - November 4, 2024 – A new case report has been published in Oncotarget's Volume 15 on October 11, 2024, entitled “A case of adenosquamous pancreatic cancer with a KRAS G12C mutation with an exceptional response to immunotherapy”

Journal: Oncotarget

Lurie Children’s to develop a novel genomic test for more rapid precision diagnosis of brain tumors

Ann & Robert H. Lurie Children's Hospital of Chicago
Grant and Award Announcement

Ann & Robert H. Lurie Children’s Hospital of Chicago was awarded $3.7 million through the National Cancer Institute Cancer Moonshot Scholars program to advance precision diagnosis of brain tumors in children. The study will be the first to apply a molecular testing technology called optical genome mapping (OGM) to achieve faster and more comprehensive diagnosis of brain tumors, so treatment can be tailored to the specific genetic changes that drive tumor growth. If successful, Lurie Children’s aims to implement this innovative clinical test by the end of the five-year study.

High levels of omega-3, omega-6 may protect against cancer

University of Georgia
Peer-Reviewed Publication

In addition to lowering your cholesterol, keeping your brain healthy and improving mental health, new research from the University of Georgia suggests omega-3 and omega-6 fatty acids may help ward off a variety of cancers.

Journal: International Journal of Cancer

Study reveals links between many pesticides and prostate cancer

Wiley
Peer-Reviewed Publication

Researchers have identified 22 pesticides consistently associated with the incidence of prostate cancer in the United States, with four of the pesticides also linked with prostate cancer mortality. The findings are published by Wiley online in CANCER.

Journal: Cancer

One-third of patients with cancer visit EDs in months before diagnosis

Canadian Medical Association Journal
Peer-Reviewed Publication

About 1 in 3 patients diagnosed with cancer in Ontario visited an emergency department (ED) in the 90 days before diagnosis, found a new study published in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.240952.

Journal: Canadian Medical Association Journal

Researchers aim to streamline cancer detection with new method for liquid biopsies

University of Rochester Medical Center
Peer-Reviewed Publication

Faster, more accurate detection of cancer cells is the goal of this University of Rochester collaborative team.

Journal: Small
Funder: NIH/National Institutes of Health

Jennifer Bickel, M.D., named MD Anderson Vice President and Chief Wellness Officer

University of Texas M. D. Anderson Cancer Center
Business Announcement

HOUSTON ― The University of Texas MD Anderson Cancer Center today announced the selection of Jennifer Bickel, M.D., as the institution’s inaugural vice president and chief wellness officer (CWO). She will begin on January 6, 2025. Working closely with the senior vice president of people, culture and infrastructure, as well as the chief academic officer, she will spearhead initiatives that prioritize employee well-being, professional fulfillment and community resilience.

Pennington Biomedical to be on display at ObesityWeek 2024 in San Antonio

Pennington Biomedical Research Center
Meeting Announcement

Pennington Biomedical Research Center researchers are gearing up and preparing to head to San Antonio for ObesityWeek 2024, presented by The Obesity Society. Pennington Biomedical will be well represented at the conference, as faculty members are not just participating in, but leading courses, presentations and speaker panels during the event.

Novel immunotherapy combo shows promise in melanoma

University of Pittsburgh
Peer-Reviewed Publication

Pre-surgery treatment with the novel drug vidutolimod and the PD-1 checkpoint inhibitor nivolumab led to tumor control in 55% of patients with stage 3 cutaneous melanoma, according to the results of a single-arm phase 2 clinical trial led by the University of Pittsburgh, UPMC Hillman Cancer Center and the National Cancer Institute (NCI).

Journal: Cancer Cell
Funder: NIH/National Institutes of Health, Melanoma Research Foundation

Regional and global experts convene in Accra, Ghana to update cancer treatment guidelines for Sub-Saharan Africa

National Comprehensive Cancer Network
Meeting Announcement

International oncology experts gather in Accra, Ghana for a series of meetings to update cancer treatment recommendations in the NCCN Harmonized Guidelines™ for Sub-Saharan Africa.